| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Real-Time Polymerase Chain Reaction | 5 | 2014 | 283 | 1.050 |
Why?
|
| beta-Lactamases | 3 | 2013 | 56 | 0.880 |
Why?
|
| Polymerase Chain Reaction | 10 | 2020 | 919 | 0.850 |
Why?
|
| DNA Primers | 5 | 2011 | 543 | 0.480 |
Why?
|
| Bacteriological Techniques | 2 | 2012 | 39 | 0.480 |
Why?
|
| Klebsiella Infections | 2 | 2012 | 30 | 0.470 |
Why?
|
| Klebsiella pneumoniae | 2 | 2012 | 40 | 0.470 |
Why?
|
| Pancreatic Neoplasms | 8 | 2024 | 684 | 0.440 |
Why?
|
| Anal Canal | 1 | 2013 | 88 | 0.420 |
Why?
|
| Neonatal Sepsis | 2 | 2023 | 5 | 0.410 |
Why?
|
| Transforming Growth Factor beta | 4 | 2024 | 326 | 0.390 |
Why?
|
| Mutation | 7 | 2024 | 4169 | 0.370 |
Why?
|
| Bacteria | 2 | 2023 | 486 | 0.370 |
Why?
|
| Adenoviridae | 3 | 2024 | 349 | 0.360 |
Why?
|
| DNA, Bacterial | 4 | 2020 | 244 | 0.340 |
Why?
|
| Oncolytic Virotherapy | 2 | 2020 | 42 | 0.340 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 46 | 0.330 |
Why?
|
| BRCA2 Protein | 1 | 2009 | 161 | 0.310 |
Why?
|
| BRCA1 Protein | 1 | 2009 | 205 | 0.300 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2007 | 17 | 0.280 |
Why?
|
| Plasmodium | 1 | 2005 | 10 | 0.250 |
Why?
|
| Malaria | 1 | 2005 | 23 | 0.250 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2010 | 106 | 0.250 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2024 | 83 | 0.240 |
Why?
|
| Adenocarcinoma | 4 | 2024 | 1185 | 0.230 |
Why?
|
| Adenoviridae Infections | 1 | 2024 | 17 | 0.230 |
Why?
|
| Circulating Tumor DNA | 1 | 2024 | 48 | 0.220 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2024 | 57 | 0.220 |
Why?
|
| Sepsis | 2 | 2023 | 329 | 0.200 |
Why?
|
| Genes, ras | 5 | 1995 | 97 | 0.200 |
Why?
|
| Bone Neoplasms | 2 | 2020 | 321 | 0.200 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2024 | 169 | 0.190 |
Why?
|
| Genetic Vectors | 2 | 2020 | 446 | 0.190 |
Why?
|
| Fetal Blood | 1 | 2021 | 93 | 0.180 |
Why?
|
| ROC Curve | 2 | 2021 | 778 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 490 | 0.180 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Oncolytic Viruses | 1 | 2019 | 24 | 0.170 |
Why?
|
| Humans | 31 | 2024 | 89985 | 0.170 |
Why?
|
| Gene Amplification | 2 | 2018 | 135 | 0.160 |
Why?
|
| Tuberculosis | 1 | 2020 | 122 | 0.160 |
Why?
|
| Immunity | 1 | 2019 | 141 | 0.150 |
Why?
|
| Staphylococcal Infections | 2 | 2014 | 272 | 0.140 |
Why?
|
| Pancreatic Ducts | 2 | 1994 | 30 | 0.140 |
Why?
|
| Influenza, Human | 2 | 2010 | 340 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2021 | 556 | 0.130 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1545 | 0.130 |
Why?
|
| Prevalence | 2 | 2023 | 1250 | 0.120 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 2018 | 0.120 |
Why?
|
| Point Mutation | 2 | 2013 | 246 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 262 | 0.120 |
Why?
|
| Base Sequence | 6 | 2007 | 2329 | 0.120 |
Why?
|
| Paraffin Embedding | 2 | 2013 | 78 | 0.110 |
Why?
|
| Formaldehyde | 2 | 2013 | 52 | 0.110 |
Why?
|
| Pancreatectomy | 1 | 2014 | 164 | 0.110 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2013 | 4 | 0.110 |
Why?
|
| Clarithromycin | 1 | 2013 | 7 | 0.110 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 39 | 0.110 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 78 | 0.110 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2013 | 40 | 0.110 |
Why?
|
| Prostatic Neoplasms | 3 | 2013 | 1747 | 0.110 |
Why?
|
| Helicobacter Infections | 1 | 2013 | 37 | 0.100 |
Why?
|
| Long-Term Care | 1 | 2013 | 61 | 0.100 |
Why?
|
| Helicobacter pylori | 1 | 2013 | 37 | 0.100 |
Why?
|
| Nucleic Acids | 1 | 2013 | 32 | 0.100 |
Why?
|
| Thyroid Diseases | 1 | 2013 | 105 | 0.100 |
Why?
|
| Gastritis | 1 | 2013 | 36 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1995 | 450 | 0.100 |
Why?
|
| Liver | 2 | 2024 | 1211 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 76 | 0.100 |
Why?
|
| Oncogenes | 2 | 1995 | 97 | 0.100 |
Why?
|
| Thyroidectomy | 1 | 2013 | 171 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 124 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2006 | 464 | 0.100 |
Why?
|
| Stomach | 1 | 2013 | 111 | 0.100 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 528 | 0.100 |
Why?
|
| Culture Media | 1 | 2012 | 147 | 0.100 |
Why?
|
| Adenoma, Islet Cell | 1 | 1992 | 28 | 0.100 |
Why?
|
| Rodentia | 1 | 1992 | 41 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 755 | 0.100 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 278 | 0.090 |
Why?
|
| Virology | 1 | 2010 | 9 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 980 | 0.090 |
Why?
|
| Viral Matrix Proteins | 1 | 2009 | 15 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2023 | 9216 | 0.090 |
Why?
|
| Neoplasms | 2 | 2022 | 3067 | 0.090 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2010 | 83 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2010 | 72 | 0.080 |
Why?
|
| Robotics | 1 | 2013 | 270 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 2588 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 6785 | 0.080 |
Why?
|
| Influenza A virus | 1 | 2010 | 172 | 0.080 |
Why?
|
| Prostatectomy | 1 | 2013 | 476 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2023 | 2497 | 0.080 |
Why?
|
| Middle Aged | 9 | 2024 | 26159 | 0.080 |
Why?
|
| Genes, BRCA2 | 1 | 2009 | 161 | 0.080 |
Why?
|
| Animals | 11 | 2024 | 27536 | 0.080 |
Why?
|
| Female | 11 | 2024 | 46602 | 0.080 |
Why?
|
| Genes, BRCA1 | 1 | 2009 | 192 | 0.080 |
Why?
|
| Species Specificity | 2 | 2007 | 685 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 486 | 0.080 |
Why?
|
| Adult | 8 | 2024 | 26827 | 0.070 |
Why?
|
| Cytokines | 2 | 2024 | 811 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 798 | 0.070 |
Why?
|
| Chlamydophila psittaci | 1 | 2007 | 2 | 0.070 |
Why?
|
| Male | 12 | 2024 | 42690 | 0.070 |
Why?
|
| Eye Neoplasms | 1 | 2007 | 27 | 0.070 |
Why?
|
| DNA | 2 | 2009 | 1311 | 0.070 |
Why?
|
| Aged | 7 | 2024 | 19262 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2023 | 318 | 0.070 |
Why?
|
| Chlamydia Infections | 1 | 2007 | 31 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 3022 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2006 | 45 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 1704 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 901 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 824 | 0.060 |
Why?
|
| Laparoscopy | 1 | 2013 | 780 | 0.060 |
Why?
|
| Staphylococcus | 1 | 2005 | 24 | 0.060 |
Why?
|
| DNA, Protozoan | 1 | 2005 | 16 | 0.060 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2005 | 34 | 0.060 |
Why?
|
| Bacterial Typing Techniques | 1 | 2005 | 28 | 0.060 |
Why?
|
| Cell Line | 1 | 2009 | 2495 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2007 | 3024 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 1732 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2007 | 261 | 0.060 |
Why?
|
| Genes, p53 | 2 | 1995 | 109 | 0.060 |
Why?
|
| Mice | 5 | 2024 | 11858 | 0.060 |
Why?
|
| Cell Communication | 1 | 2005 | 200 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 855 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2005 | 314 | 0.060 |
Why?
|
| Mesocricetus | 5 | 1995 | 105 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 1995 | 160 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 165 | 0.050 |
Why?
|
| Cricetinae | 5 | 1995 | 558 | 0.050 |
Why?
|
| Autopsy | 1 | 2023 | 124 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2024 | 3404 | 0.050 |
Why?
|
| Liquid Biopsy | 1 | 2022 | 36 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 885 | 0.050 |
Why?
|
| Placenta | 1 | 2023 | 181 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 415 | 0.050 |
Why?
|
| Umbilical Cord | 1 | 2021 | 40 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1866 | 0.050 |
Why?
|
| DNA, Neoplasm | 2 | 2013 | 266 | 0.050 |
Why?
|
| Hospitals | 2 | 2013 | 303 | 0.040 |
Why?
|
| Carcinogens | 3 | 1995 | 111 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2019 | 57 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2007 | 173 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 140 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 160 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 153 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2395 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 2769 | 0.040 |
Why?
|
| Class II Phosphatidylinositol 3-Kinases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 1048 | 0.040 |
Why?
|
| Gene Expression | 2 | 1994 | 1309 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 816 | 0.040 |
Why?
|
| Methylnitrosourea | 2 | 1994 | 7 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 173 | 0.040 |
Why?
|
| Virus Replication | 1 | 2019 | 326 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 981 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 94 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 276 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 778 | 0.040 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 204 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 3800 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 405 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 3046 | 0.030 |
Why?
|
| Cell Aggregation | 2 | 2006 | 39 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1992 | 1284 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 2006 | 103 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1995 | 21 | 0.030 |
Why?
|
| Keratin-19 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 869 | 0.030 |
Why?
|
| Nitrosourea Compounds | 1 | 1994 | 9 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 67 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1994 | 50 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 79 | 0.030 |
Why?
|
| Child | 2 | 2020 | 7242 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 5358 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 6415 | 0.030 |
Why?
|
| Fixatives | 1 | 2013 | 12 | 0.030 |
Why?
|
| Electrophoresis | 1 | 2013 | 55 | 0.030 |
Why?
|
| Exons | 2 | 1995 | 453 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2013 | 40 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 9345 | 0.030 |
Why?
|
| Kallikreins | 1 | 2013 | 46 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 88 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2013 | 70 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2010 | 3773 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2013 | 151 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 899 | 0.030 |
Why?
|
| Chromogenic Compounds | 1 | 2012 | 5 | 0.030 |
Why?
|
| Agar | 1 | 2012 | 8 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2013 | 103 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 848 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1452 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 983 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 1169 | 0.020 |
Why?
|
| Illinois | 1 | 2013 | 485 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 1992 | 183 | 0.020 |
Why?
|
| Rectum | 1 | 2012 | 148 | 0.020 |
Why?
|
| Trout | 1 | 1991 | 2 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1497 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1992 | 201 | 0.020 |
Why?
|
| General Surgery | 1 | 2013 | 236 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 866 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 341 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1995 | 728 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2009 | 50 | 0.020 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1990 | 117 | 0.020 |
Why?
|
| Introns | 1 | 1991 | 301 | 0.020 |
Why?
|
| Adenoma | 1 | 1992 | 251 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 1184 | 0.020 |
Why?
|
| Nitrosamines | 3 | 1995 | 8 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1994 | 2887 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2886 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 1434 | 0.020 |
Why?
|
| Mass Screening | 1 | 2012 | 647 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2026 | 0.020 |
Why?
|
| Chemotactic Factors | 1 | 2005 | 14 | 0.020 |
Why?
|
| Transition Temperature | 1 | 2005 | 11 | 0.020 |
Why?
|
| DNA Probes | 1 | 2005 | 77 | 0.020 |
Why?
|
| Blood | 1 | 2005 | 69 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2005 | 176 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2005 | 96 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2005 | 251 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 692 | 0.010 |
Why?
|
| Collagen | 1 | 2005 | 294 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 3189 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 354 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 787 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 1995 | 31 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 391 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 418 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 645 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1995 | 340 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1992 | 152 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 665 | 0.010 |
Why?
|